Bibliographic information
Guideline—
Year of Publication—
Issuing Institution—
Recommendation
Maintained
Originally developed
In patients with confirmed rifampicin-susceptible, isoniazid-resistant tuberculosis (Hr-TB), treatment with rifampicin, ethambutol, pyrazinamide and levofloxacin is recommended for a duration of 6 months
Recommended in favor
Conditional
Certainty of evidence
Very low